Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease.
Chiara PisettaClaudia ChillèGiovanni PelizzariMarie Graciella PigozziMassimo SalvettiAnna PainiMaria Lorenza MuiesanCarolina De CiuceisChiara RicciDamiano RizzoniPublished in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2020)
Some of the methods for the estimation of cardiovascular risk (ACC/AHA ASCVD 2013, new model 2 2018, and, also Framingham score 2008) have a clear advantage over Framingham score 2004 and "Progetto Cuore" of the Italian Institute of Health in terms of correlation with the severity of NAFLD. They are, therefore, more clinically useful.